Europe & Central Asia (excluding high income) vs India: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and

Europe & Central Asia (excluding high income)
14.5%
in 2021
India
23.0%
in 2021
Europe & Central Asia (excluding high income) rank
29th
India rank
32nd

Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and over time

  • Europe & Central Asia (excluding high income)
  • India
0510152025200020102021

How they compare

India currently reports 23.0% against 14.5% in Europe & Central Asia (excluding high income), a difference of 8.5%.

That makes India's figure about 1.6 times Europe & Central Asia (excluding high income)'s.

The two have swapped places 1 time across 22 shared years of data; in 2000 it was Europe & Central Asia (excluding high income) ahead.

Europe & Central Asia (excluding high income) ranks 29th and India ranks 32nd of 47 groups.

Across the 3 decades both report, Europe & Central Asia (excluding high income) averaged higher in 1 and India in 2.

Head to head by decade

Decade Europe & Central Asia (excluding high income) India Difference Ahead
2000s 21.4% 18.9% 2.5% Europe & Central Asia (excluding high income)
2010s 16.6% 19.7% 3.0% India
2020s 14.5% 21.6% 7.1% India

Averages of every year both report within each decade.

Frequently asked questions

Which has higher mortality from cvd, cancer, diabetes or crd between exact ages 30 and, Europe & Central Asia (excluding high income) or India?
India, at 23.0% against 14.5% in Europe & Central Asia (excluding high income) as of 2021.
What is the difference in mortality from cvd, cancer, diabetes or crd between exact ages 30 and between Europe & Central Asia (excluding high income) and India?
8.5%, with India ahead.
How many years of comparable data are there for Europe & Central Asia (excluding high income) and India?
22 years are reported by both, from 2000 to 2021.
How do Europe & Central Asia (excluding high income) and India rank globally for mortality from cvd, cancer, diabetes or crd between exact ages 30 and?
Europe & Central Asia (excluding high income) ranks 29th and India ranks 32nd of 47 groups.
Where does this data come from?
World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO), published as Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Europe & Central Asia (excluding high income) vs India: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and. Statizoid, drawing on World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO). Retrieved 18 September 2026, from https://health.statizoid.com/compare/mortality-from-cvd-cancer-diabetes-or-crd-between-exact-ages-30-and-70-female-percent/europe-and-central-asia-excluding-high-income/india/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/mortality-from-cvd-cancer-diabetes-or-crd-between-exact-ages-30-and-70-female-percent/europe-and-central-asia-excluding-high-income/india/">Europe & Central Asia (excluding high income) vs India: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and</a> — Statizoid

About this data

Indicator
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%)
Unit
%
Source
World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
232 places, 5,104 data points, 2000–2021
Last refreshed

Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).